Description

Burgues et al evaluated the response of men with hypogonadotrophic hypogonadism to subcutaneous injections of follicle stimulating hormone (FSH) and human chorionic gonadogrophin (HCG). The authors are from multiple hospitals in Spain.


 

Patient selection: male with hypogonadotrophic hypogonadism with azoospermia or aspermia from 18 to 45 years of age

 

Injection of purified FSH and HCG (which provides LH activity) takes some time to be effective so monitoring should be over the year after starting although some patients may show an early improvement.

 

Responses to therapy:

(1) sperm count

(2) change in male physical findings

 

change in sperm count =

= (sperm count after therapy) – (sperm count before starting therapy)

Sperm Count

Response

no change

nonresponder

an increase but count less than 1 M per mL sperm

partial response

>= 1 M per mL

complete respoonse

 

A person who responds will have:

(1) an increase ejaculate volume

(2) an increase in penis length

(3) increase in Tanner stage for male hair distribution (from prepubertal)

(4) increase in serum testosterone to the normal range

(5) increase in testicular volume

 

Failure to respond:

(1) poor compliance

(2) delayed but eventual response

(3) wrong diagnosis

 


To read more or access our algorithms and calculators, please log in or register.